Aura Biosciences
AURA
117 hedge funds and large institutions have $274M invested in Aura Biosciences in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 8 closing their positions.
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
10% more funds holding
Funds holding: 106 → 117 (+11)
4.04% less ownership
Funds ownership: 83.14% → 79.11% (-4%)
11% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 38
14% less capital invested
Capital invested by funds: $319M → $274M (-$45.4M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.57M |
| 2 |
BlackRock
New York
|
+$920K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$766K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$489K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$407K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.31M |
| 2 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$3.61M |
| 3 |
LCS
Levin Capital Strategies
New York
|
-$3.51M |
| 4 |
CP
Caligan Partners
New York
|
-$1.4M |
| 5 |
DC
Decheng Capital
Menlo Park,
California
|
-$921K |
AURA Hedge Fund Activity: Q4 2025 in Review
117 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q4 2025, worth a combined $274M — down 14% from $319M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new AURA positions and 8 closed out — a net gain of 11 holders — while 34 added to existing stakes and 38 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.57M. The largest seller was UBS Group, cutting an estimated $4.31M.
- 117 institutional investors held Aura Biosciences (AURA) as of Q4 2025, up from 106 in Q3 2025.
- Funds reported $274M of Aura Biosciences stock for Q4 2025, down 14% quarter-over-quarter.
- 19 funds opened new Aura Biosciences positions in Q4 2025 and 8 closed out, a net change of +11 holders.
- The largest Aura Biosciences buyer in Q4 2025 was Millennium Management, an estimated $2.57M added.
- The largest Aura Biosciences seller in Q4 2025 was UBS Group, an estimated $4.31M sold.
Based on aggregated 13F filings for Q4 2025.